in the United States of America out of 253,000. However, considerable information about thyroid cancer is accumulated in the many hundreds of cases reported, chiefly in the United States of America, during the past 15 years. Aspects of particular interest are the comparatively high incidence in children, the remarkably protracted course in many patients and the therapeutic effects of radioactive iodine on the one hand and of thyroxine on the other. Further, views have changed radically in recent years on the aetiological significance in thyroid cancer of iodine deficiency, thyroid adenomata and previous irradiation of the thyroid gland.
Aetiology
Clinicians and pathologists have long been aware that thyroid carcinoma may be divided into two main groups: a slow growing, though metastasizing, histologically differentiated type and a rapidly growing, rapidly fatal, undifferentiated type. The assumption formerly accepted that many of the differentiated cancers arise in adenomas is giving way to the concept that these malignant tumours are low grade carcinomas from the start and that thyroid adenomas show little or no predisposition to malignant change.5 This concept is supported by the finding that in contrast to the rarity of thyroid carcinoma, adenomas are present in about one-fourth of all post-mortem thyroids'-and by the that IO out of 28 children with thyroid cancer had been submitted to X-irradiation of the thymus in infancy stimulated a series of investigations which have established that gamma or X-irradiation to the thyroid gland in infants and children carries a risk of the development of thyroid carcinoma in childhood or adult life. Thus, io out of I,502 children, traced out of a total of 1,722 who had received a few hundred rads to the thyroid in the course of therapeutic irradiation of the thymus in infancy subsequently developed thyroid cancer, whereas none developed in I,933 non-irradiated sibs. ' 8 Approximately 20% of all children with thyroid carcinoma in the United States of America give a history of therapeutic X-irradiation to the thymus in infancy.2' It is an interesting paradox that no thyroid cancers have been attributed to therapeutic X-irradiation or treatment with radioactive iodine for hyperthyroidism in adult life. It has been suggested that malignant change initiated in infant thyroid cells by small doses of irradiation might be promoted to tumour formation by the natural mitotic tenfold growth of the gland from infancy to puberty, whereas in the adult thyroid submitted to therapeutic irradiation, ability of the heavily irradiated cells to sur- vive division is damaged and thereby tumour formation might be inhibited.7
The prolonged treatment of rats with goitrogens results regularly in the induction of thyroid hyperplasia, adenomas and eventually of metastasizing carcinomas.16 The hyperplasia results from the goitrogenic-conditioned excessive secretion of thyrotrophic hormone.'6 It must be emphasized that the degree of thyrotrophic stimulation is intense in these experiments and must be prolonged for at least two-thirds of the rats' lifetime before carcinomas develop. The Approximately I 5°/ of the differentiated thyroid carcinomas occur in children and young adults; the cell type is predominantly papillary. The remainder occur throughout middle and old age when both cell types are seen but the follicular predominates. The overall sex ratio is i male to 4 females, but in children it is nearer i to i. The chief sites of metastasis are lymph-borne to the cervical and upper mediastinal lymph nodes, and blood-borne to the skeleton and lungs. The predominantly papillary cancers spread to the nodes and occasionally to lungs and bones. The follicular carcinomas also spread to nodes but show a greater tendency to metastasize to bones. Radiographic evidence of pulmonary metastases may be present for years without overt interference with lung function. Skeletal metastases are osteolytic, painful and deforming and interfere with function. Slow growing, widespread metastases may reach a total mass of some kilograms and very occasionally produce hyperthyroidism. The functional ability of follicular thyroid carcinoma has led to the application of radioactive iodine both for the identification of the nature and distribution of metastases and for radiation therapy. After ablation or removal of the competing thyroid gland, radioactive iodine may be taken up by metastases in quantities sufficient for their recognition and destruction. Functioning growths usually show a follicular pattern with colloid formation,9 though not all well-differentiated follicular carcinomas are able to concentrate and bind iodine. The varied morphology of metastases in the same patient is reflected in varying avidity for iodine. The recognition of function in thyroid carcinomas and their hormone dependency has led to treatment with thyroxine. This is given in sufficient dosage to inhibit endogenous secretion of pituitary thyrotrophic hormone and thus remove any hormonal stimulus to growth of the carcinoma. It has been observed that this treatment leads occasionally to disappearance of the tumour and of pulmonary metastases. 4 Crile believes that the raised secretion of thyrotrophic hormone which follows removal of the thyroid gland might lead through hormonally-induced proliferation of differentiated tumour cells to development of anaplastic hormone-independent forms. There is a conflict of views between experts with regard to the choice of radical surgery, radioactive iodine or thyroxine therapy in the treatment of differentiated thyroid carcinoma. Undifferentiated thyroid carcinoma grows with frightening rapidity, usually in elderly women with no history of previous goitre, killing within a few months, often as a result of malignant ulceration of the trachea. The histological types described are giant-celled, spindle-celled and small round-celled. The picture may be mixed. The giant cells are both single and multinucleated (Fig. 6) . The spindle-celled tumours are sarcomatous in appearance (Fig. 7 ' anaplastic carcinoma' of the thyroid about one-third survived unexpectedly well after resection of the thyroid and radiotherapy to the neck.2 A number of the survivors turned up within a few years with deposits of malignant lymphoma in the stomach or small intestine. The finding of a slowly growing malignant lymphoma, restricted for a few years to one organ and its draining lymph nodes and not rarely cured by resection of the diseased tissue, is recognized in stomach, small intestine, bone and lungs. It is therefore acceptable in the thyroid too. The difficulty for the pathologist is that though histological examination yields the diagnosis it is not possible to foretell from the microscopical appearances whether the patient will die in a few months from spread of the lymphoma in spite of post-operative radiotherapy and thyroxine, or survive many years in perfect health on thyroxine medication (except for the possible perforation of small intestine by infiltration of a deposit of malignant lymphoma). Nor in truth can the histologist be confident that any group of cases of malignant lymphoma is not in reality a heterogeneous collection of thyroid diseases. These may consist variously of examples of particularly vicious-looking diffuse thyroiditis, or of anaplastic round-celled carcinoma, or of malignant lymphoma including lymphosarcoma and reticulosarcoma.
